Disorders of glycosaminoglycans (mucopolysaccharides) and proteoglycans

Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition

Volumn , Issue , 2007, Pages 877-900

  Klintworth, Gordon K ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952952752     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (278)

1. Aberfeld DC, Hinderbuchner LP, Schneider M. Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome). Brain 1965; 88:313-22.
2. Aguirre G, Raber I, Yanoff M, Haskins M. Reciprocal corneal transplantation fails to correct mucopolysaccharidosis VI corneal storage. Invest Ophthalmol Vis Sci 1992; 33:2702-13.
3. Aguirre G, Stramm L, Haskins M. Feline mucopolysaccharidosis VI: General ocular and pigment epithelial pathology. Invest Ophthalmol Vis Sci 1983; 24:991-1007.
4. Aguirre G, Stramm L, Haskins M, Jezyk P. Animal Models of Metabolic Eye Diseases. In: Renie WA, ed. Goldberg’s Genetic and Metabolic Eye Disease. Boston, MA: Little, Brown and Company, 1986:139-67.
5. Akama TO, Nishida K, Nakayama J, et al. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet 2000; 26:237-41.
6. Ala-Kapee M, Nevanlinna H, Mali M, et al. Localization of gene for human syndecan, an integral membrane proteoglycan and a matrix receptor, to chromosome 2. Somat Cell Molec Genet 1990; 16:501-5.
7. Aleu F, Terry RD, Zellweger H. Electron microscopy of two cerebral biopsies in gargoylism. J Neuropath Exp Neurol 1965; 24:304-17.
8. Anseth A. Studies on corneal polysaccharides. V. Changes in corneal glycosaminoglycans in transient stromal edema. Exp. Eye Res. 1969; 8:297-301.
9. Anseth A. Studies on corneal polysaccharides. VII Changes in the glycosaminoglycans in penetrating corneal grafts. Exp Eye Res 1969; 8:310-4.
10. Anseth A. Studies on corneal polysaccharides. VIII Changes in the glycosaminoglycans in some human corneal disorders. Exp Eye Res 1969; 8:438-41.
11. Anseth A, Fransson LA. Studies on corneal polysaccharides. VI. Isolation of dermatan sulfate from corneal scar tissue. Exp Eye Res 1969; 8:302-9.
12. Anseth A, Laurent TC. Polysaccharides in normal and pathologic corneas. Invest Ophthalmol 1962; 1:195-201.
13. Antonsson P, Heinegard D, Oldberg A. The keratan sulfate-enriched region of bovine cartilage proteoglycan consists of a consecutively repeated hexapeptide motif. J Biol Chem 1989; 264:16170-3.
14. Antonsson P, Heinegard D, Oldberg A. Posttranslational modifications of fibromodulin. J Biol Chem 1991; 266:16859-61.
15. Arikawa-Hirasawa E, Le AH, Nishino I, et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 2002; 70 1368-75.
16. Austin BA, Coulon C, Liu CY, et al. Altered collagen fibril formation in the sclera of lumican-deficient mice. Invest Ophthalmol Vis Sci 2002; 43:1695-701.
17. Axelsson I, Heinegard D. Characterization of chondroitin sulfate-rich proteoglycans from bovine corneal stroma. Exp Eye Res 1980; 31:57-66.
18. Bach G, Eisenberg F Jr, Cantz M, Neufeld EF. The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase. Proc Natl Acad Sci USA 1973; 70:2134-8.
19. Balduini, C, De Luca, G, Passi, A, et al. Effect of oxygen tension and lactate concentration on keratan sulphate and chondroitin sulphate biosynthesis in bovine cornea. Biochim Biophys Acta 1992; 1115:187-91.
20. Bech-Hansen NT, Naylor MJ, Maybaum TA, et al. Mutations in NYX, encoding the leucine rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nature Genet 2000; 26:319-23.
21. Berndt C, Casaroli-Marano RP, Vilaro S, Reina M. Cloning and characterization of human syndecan-3. J Cell Biol 2001; 82:246-59.
22. Bezakova G, Ruegg MA. New insights into the roles of agrin. Nat Rev Mol Cell Biol 2003; 4:295-308.
23. Birkenmeier E.H, Davisson MT, Beamer WG, et al. Murine mucopolyssacharidosis type VII: characterization of a mouse with b-glucuronidase deficiency. J Clin Invest 1989; 83:1258-66.
24. Blochberger TC, Vergnes J-P, Hempel J, Hassell JR. cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem 1992; 267:347-52.
25. Bobardt MD, Saphire ACS, Hung H-C, et al. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 2003; 18:27-39.
26. Borcherding MS, Blacik LJ, Sittig RA, et al. Proteoglycans and collagen fibre organization in human corneoscleral tissue Exp Eye Res 1975; 21:59-70.
27. Brante G. Gargoylism: a mucopolysaccharidosis. Scand J Clin Lab Invest 1952; 4:43-6.
28. Bredrup C, Knappskog P M, Majewski J, et al. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthal Vis Sci 2005; 46:420-6.
29. Bredrup C, Knappskog PM, Majweski J, et al. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthamol Vis Sci 2005; 46:420-6.
30. Breider MA, Shull RM, Constantopoulos G. Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I. Am J Pathol 1989; 134:677-92.
31. Brown DH. Tissue storage of mucopolysaccharides in Hurler-Pfaundler’s disease. Proc Natl Acad Sci USA 1957; 43:783-90.
32. Brown SI, Kuwabara T. Peripheral corneal opacification and skeletal deformities: a newly recognized acid mucopolysaccharidosis simulating rheumatoid arthritis. Arch Ophthalmol 1970; 83:667-77.
33. Bülow, H.E., Hobert, O. The molecular diversity of glycoaminoglycans shapes animal development. Annu. Rev. Cell Dev. Biol. 2006; 22:375--407, 2006.
34. Buscaino GA. Difficile inquadramento di una forma clinica di osteochondrodistrofia associata a disturbi neurologici di tipo extrapiramidale. Studio clinicobiochimico in 4 fratelli. Acta Neurol 1968; (Napoli) 23:34-60.
35. Cantz AM, Chrambach A, Neufeld EF. Characterization of the factor deficient in the Hunter syndrome by polyacrylamide gel electrophoresis. Biochem Biophys Res Commun 1970; 39:936-42.
36. Carey DJ, Evans DM, Stahl RC, et al. Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J Cell Biol 1992; 117:191-201.
37. Castoro, JA, Bettelheim, AA, Bettelheim, FA. Water gradients across bovine cornea. Invest Ophthalmol Vis Sci 1988; 29:963-8.
38. Chakravarti S, Stallings RL Sundar Raj N, et al. Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics 1995; 27:481-8.
39. Chijiiwa T, Inomata H, Yamana Y, Kaibara N. Ocular manifestations of Hurler/Scheie phenotype in two sibs. Jap J Ophthalmol 1983; 27:54-62.
40. Cintron C, Covington HI, Kublin CL. Morphologic analyses of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci 1990; 31:1789-98.
41. Cintron C, Gregory JD, Damle SP, Kublin CL. Biochemical analyses of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci 1990; 31:1975-81.
42. Cole GJ, Burg M. Characterization of a heparan sulfate proteoglycan that copurifies with the neural cell adhesion molecule. Exp Cell Res 1989; 182:44-60.
43. Constantopoulos G, Scott JA, Shull RM. Corneal opacity in canine MPS I Invest Ophthalmol Vis Sci 1989; 30:1802-7.
44. Cornelison DDW, Wilcox-Adelman SA, Goetinck PF, et al. Essential and separable roles for syndecan-3 and syndecan-4 in skeletal muscle development and regeneration. Genes Dev 2004; 18:2231-6.
45. Cornet PK, Blochberger TC, Hassel JR. Molecular polymorphism of lumican during corneal development. Invest Ophthalmol Vis Sci 1994; 35:870-7.
46. Crawford M. d’A, Dean MF, Hunt DM, et al. Early prenatal diagnosis of Hurler’s syndrome with termination of pregnancy and confirmatory findings on the fetus. J Med Genet 1973; 10:144-53.
47. Dahl IMS, Laurent TC. Synthesis of glycosaminoglycans in corneal organ cultures. Exp Eye Res 1982; 34:83-98.
48. Danes BS. Variant of iduronidase deficient mucopolysaccharidoses:further evidence for genetic heterogeneity. J Med Genet 1977; 14:346-51.
49. Danielson KG, Fazzio A, Cohen I, et al. The human decorin gene: intron-exon organization, discovery of two alternatively spliced exons in the 5-prime untranslated region, and mapping of the gene to chromosome 12q23. Genomics 1993; 15:146-60.
50. David G, van der Schueren B, Marynen P, et al. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992; 118:961-9.
51. Davis DB, Currier FP. Morquio’s disease: report of two cases. J Am Med Assoc 1934; 102:2173-6.
52. Deere M, Johnson J, Garza S, et al. Characterization of human DSPG3, a small dermatan sulfate proteoglycan. Genomics 1996; 38:399-04.
53. Dekaban AS, Patton VM. Hurler’s and Sanfilippo’s variants of mucopolysaccharidosis: cerebral pathology and lipid chemistry. Arch Pathol 1971; 91:434-43.
54. Desvignes P, Pouliquen Y, Legras M, Guyot JD. Aspect clinique, examen histologique et structural d’une cornée dystrophique de maladie de Hurler. Bull Mem Soc Fr Ophtalmol 1967; 80:43-8.
55. Di Ferrante N, Ginsberg LC, Donnelly PV, et al. Deficiencies of glucosamine-6-sulfate or galactosamine-6-sulfate sulfatases are responsible for different mucopolysaccharidoses. 1978; Science 199:79-81.
56. Dodge GR, Kovalszky I, Chu M-T, et al. Heparan sulfate proteoglycan and human colon: partial molecular cloning, cellular expression and mapping of the gene (HSPG2) to the short arm of human chromosome 1. Genomics 1991; 10:673-80.
57. Doege KJ, Sasaki M, Kimura T, Yamada Y. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 1991; 266:894-902.
58. Dohlman CH, Praus R. The mucopolysaccharides in corneal wound healing. In: Dardenne MU, Nordmann J, eds. Biochemistry of the Eye. Basel, S. Karger, 1968:120-7.
59. Dorfman A, Lorincz AE. Occurrence of urinary acid mucopolysaccharides in the Hurler syndrome. Proc Natl Acad Sci USA 1957; 43:443-6.
60. Edmison DR, Robertson DM, Rosen DA. Corneal mucopolysaccharidosis:light and electron microscopic study of an atypical case after keratoplasty. Can J Ophthalmol 1972; 7:271-6.
61. Escourolle R, Berger B, Poirier J. Biopsie cérébrale d’un cas de mucopolysaccharidose H.S. (oligophrénie polydystrophique ou maladie de Sanfilippo). Étude histochimique et ultrastructurale. Presse Med 1966; 74:2869-74.
62. Esko JD. Genetic analysis of proteoglycan structure, function and metabolism. Curr Opin Cell Biol 1991; 3:805-16.
63. Ethier CR, Kamm RD, Palaszewski BA, et al. Calculations of flow resistance in the juxtacanalicular meshwork. Invest Ophthalmol Vis Sci 1986; 27:1741-50.
64. Filmus J. Mini Review. Glypicans in growth control and cancer. Glycobiology 2001; 11:19R-23R.
65. Fisher LW, Heegaard AM, Vetter U, et al. Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization. J Biol Chem 1991; 266:14371-7.
66. Fitch N, Karpati G, Pinsky L. Congenital blepharophimosis, joint contractures, and muscular hypotonia. Neurology 1971 21: 1214-20.
67. Fluharty AL, Stevens RL, Sanders DL, Kihara H. Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts. Biochem Biophys Res Commun 1974; 59:455-61.
68. Fransson L-A, Sjöberg I, Dorfman A, Matalon R. Chemistry of dermatan sulphate accumulated intracellularly in Hunter’s disease. In: Holton JB, Ireland JT, eds. Inborn Errors of Skin Hair and Connective Tissue. Baltimore, University Park Press, 1975:179-96.
69. Frantantoni JC, Hall CW, Neufeld EF. The defect in Hurler’s and Hunter’s syndromes: faulty degradation of mucopolysaccharides. Proc Natl Acad Sci USA 1968; 60:699-706.
70. Frantantoni JC, Hall CW, Neufeld EF. Hurler and Hunter syndromes: mutual correction of defect in cultured fibroblasts. Science 1968; 162:570-2.
71. Frantantoni JC, Hall CW, Neufeld EF. The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation. Proc Natl Acad Sci USA 1969; 64:360-6.
72. Freitag F, Kuchemann K, Schuster W, Spranger J. Hepatic ultrastructure in chondroitin-4-sulfate mucopolysaccharidosis. Virchows Arch Abt B Zellpathol 1971; 8:1-15.
73. Friedman JS, Faucher M, Hiscott P, et al. Protein localization in the human eye and genetic screen of opticin. Hum Molec Genet 2002; 11:1333-42.
74. Frydman M, Steinberger J, Shabtai F, Steinherz R. Interstitial 7q deletion (46, XY, del(7)(pter cen::q112qtr)) in a retarded quadriplegic boy with normal betaglucuronidase. Am J Med Genet 1986; 25:245-9.
75. Fukai N, Eklund L, Marneros AG, et al. Lack of collagen XVIII/endostatin results in eye abnormalities. Embo J 2002; 21:1535-44.
76. Funderburgh JL, Caterson B, Conrad GW. Keratan sulfate proteoglycan during embryonic development of the chicken cornea. Dev Biol 1986; 116:267-77.
77. Funderburgh JL, Chandler JW. Proteoglycans of rabbit corneas with nonperforating wounds. Invest Ophthalmol Vis Sci 1989; 30:435-42.
78. Funderburgh JL, Cintron C, Covington HI, Conrad GW. Immunoanalysis of keratan sulfate proteoglycan from corneal scars. Invest Ophthalmol Vis Sci 1988; 29:1116-24.
79. Funderburgh JL, Funderburgh ML, Mann MM, Conrad GW. Arterial lumican: properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J Biol Chem 1991; 266:24773-7.
80. Funderburgh JL, Funderburgh ML, Rodrigues MM, et al. Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases. Invest Ophthalmol Vis Sci 1990; 31:419-28.
81. Funderburgh JL, Panjwani N, Conrad GW, Baum J. Altered keratan sulfate epitopes in keratoconus. Invest Ophthalmol Vis Sci 1989; 30:2278-81.
82. Gasper PW, Thrall MA, Wenger DA, et al. Correction of feline arylsulfatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature 1984; 312:467-9.
83. Ghiselli G, Iozzo RV. Overexpression of bamacan/SMC3 cusese transformation. J Biol Chem 2000; 275:20235-8.
84. Ghosh M, McCulloch C. The Morquio syndrome: light and electron microscopic findings from two corneas. Can J Ophthalmol 1974; 9:445-52.
85. Ginsberg LC, Donnelly PV, Di Ferrante DT, et al. Nacetylglucosamine-6-sulfate sulfatase in man: deficiency of the enzyme in a new mucopolysaccharidosis. Pediatr Res 1978; 12:805-9.
86. Gleghorn L, Ramesar R, Beighton P, Wallis G. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepihyseal dysplasia associated with severe, premature osteoarthritis. Am J Hum Genet 2005; 77:484-90.
87. Goetinck PF. Proteoglycans in development. Curr Topics Develop Biol 1991; 25:111-31.
88. Goldberg MF, Duke JR. Ocular histopathology in Hunter’s syndrome: systemic mucopolysaccharidosis type II. Arch Ophthalmol 1967; 77:503-12.
89. Goldberg, MF, Scott CI, McKusick VA. Hydrocephalus and papilledema in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Am J Ophthalmol 1970; 69:969-75.
90. Goldman JN, Benedek GB, Dohlman CH, Kravitt B. Structural alterations affecting transparency in swollen human corneas. Invest Ophthalmol 1968; 7:501-19.
91. Gonatas NK, Gonatas J. Ultrastructural and biochemical observations on a case of systemic late infantile lipidosis and its relationship to Tay-Sachs disease and gargoylismus. J Neuropath Exp Neurol 1965; 24:318-40.
92. Goodman WM, SundarRaj N, Garone M, et al. Unique parameters in the healing of linear partial thickness penetrating corneal incisions in rabbit: immunohistochemical evaluation. Curr Eye Res 1989; 8:305-16.
93. Gould SE, Upholt WB, Kosher RA. Syndecan 3: a member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation. Proc Natl Acad Sci USA 1992; 89:3271-5.
94. Gregory JD, Coster L, Damle SP. Proteoglycans of rabbit corneal stroma: isolation and characterization. J Biol Chem 1982; 257:6965-70.
95. Groth C, Ringden O. Transplantation in relation to the treatment of inherited disease. Transplantation 1984; 38:319-27.
96. Grover J, Chen X-N, Korenberg JR, et al. The gene organization, chromosome location, and expression of a 55-kDa matrix protein (PRELP) of human articular cartilage. Genomics 1996; 38:109-17.
97. Hall CW, Cantz M, Neufeld EF. A b-glucuronidase deficiency mucopolysaccharidosis: studies in cultured fibroblasts. Arch Biochem Biophys 1973; 155:32-8.
98. Harris RC. Mucopolysaccharide disorder: a possible new genotype of Hurler’s syndrome. Am J Dis Child 1961; 102:741-2.
99. Haskins M, Aguirre G, Jezyk P, et al. The pathology of the feline model of mucopolysaccharidosis I Am J Pathol 1983; 112:27-36.
100. Haskins ME, Aguirre GD, Jezyk PF, et al. Animal model of human disease. Mucopolysaccharidosis type VII (Sly syndrome): beta-glucuronidase-deficient mucopolysaccharidosis in the dog. Am J Path 1991; 138:1553-5.
101. Haskins ME, Aguirre GD, Jezyk P, Patterson DF. The pathology of the feline model of mucopolysaccharidosis VI. Am J Pathol 1980; 101:657-74.
102. Haskins M, Baker H, Birkenmeier E, et al. Transplantation in animal model systems. In: Desnick R, ed. Therapy of Genetic Disease. New York, NY: Churchill Livingston, 1992:183-201.
103. Haskins ME, Desnick RJ, DiFerrante N, et al. Betaglucuronidase deficiency in a dog: a model for human mucopolysaccharidosis VII. Pediatr Res 1984; 10:980-4.
104. Hassell JR, Blochberger TC, Rada JA, et al. Proteoglycan gene families. In: Kleinman H, ed. Advances in Molecular and Cell Biology, vol. 7. Greenwich, CT: The Extracellular Matrix, JAI Press, 1993.
105. Hassell JR, Cintron C, Kublin C, Newsome DA. Proteoglycan changes during restoration of transparency in corneal scars. Arch Biochem Biophys 1983; 222:362-9.
106. Hassell JR, Newsome DA, Hascall VC. Characterization and biosynthesis of proteoglycans of corneal stroma from rhesus monkey. J Biol Chem 1979; 254:12346-54.
107. Hassell J, Robey PG, Barrach HJ, et al. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci USA 1980; 77:4494-8.
108. Heathcote JG, Bruns RR, Orkin RW. Biosynthesis of sulphated macromolecules by rabbit lens epithelium. II. Relationship to basement membrane formation. J Cell Biol 1984; 99:861-9.
109. Horwitz AL, Dorfman A. The enzymic defect in Morquio’s disease: the specificity of N-acetyl-hexosamine sulfatases. Biochem Biophys Res Comm 1978; 80:819-25.
110. Hugh-Jones K, Hobbs J, Chambers D, et al. Bone marrow transplantation in mycopolysaccharidosis. In: Barranger JA, Brady, RO, eds. Molecular Basis of Lysosomal Storage Disorders. New York, NY: Academic Press, 1984:411-28.
111. Humphries DE, Nicodemus CF, Schiller V, Stevens RL. The human serglycin gene: nucleotide sequence and methylation pattern in human promyelocytic leukemia HL-60 cells and T-lymphoblast Molt-4 cells. J Biol Chem 1992; 267:13558-63.
112. Hunter C. A rare disease in two brothers. Proc R Soc Med 1917; 10:104-16.
113. Hurler G. Über einen Type multipler Abartungen, vorwiegend am Skellettsystem. Z Kinderheilkd 1919; 24:220-34.
114. Iozzo RV. Proteoglycans: structure, function, and role in neoplasia. Lab Invest 1985; 53:373-96.
115. Iozzo RV, Naso MF, Cannizzaro LA, et al. Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). Genomics 1992; 14:845-51.
116. Ivins JK, Litwack ED, Kumbasar A, et al. Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. Dev Biol 1997; 184:320-32.
117. Jeanloz RW. The nomenclature of acid mucopolysaccharides. Arthritis Rheum 1960; 3:323-7.
118. Jensen OA, Pederson C, Schwartz M, et al. Hurler/Scheie phenotype: report of an inbred sibship with tapeto-retinal degeneration and electron-microscopic examination of the conjunctiva. Ophthalmologica 1978; 176:194-204.
119. Jepsen KJ, Wu F, Peragallo JH, et al. A syndrome of joint laxity and impaired tendon integrity in lumican-and fibromodulin-deficient mice. J Biol Chem 2002; 277:35532-40.
120. Jervis GA. Familial mental deficiency akin to amaurotic idiocy and gargoylism: an apparently new type. Arch Neurol Psychiatr 1942; 47:943-61.
121. Jones ST, Zimmerman LE. Histopathologic differentiation of granular, macular and lattice dystrophies of the cornea. Am J Ophthalmol 1961; 51:394-410.
122. Jost CJ, Funderburgh JL, Mann M, et al. Cell-free translation and characterization of corneal keratan sulfate proteoglycan core proteins. J Biol Chem 1991; 266:13336-41.
123. Kaibara N, Eguchi M, Shibata K, Takugishi K. Hurler-Scheie phenotype: a report of two pairs of inbred sibs. Hum Genet 1979; 53:37-41.
124. Kajii T, Matsuda I, Ohsawa T, et al. Hurler/Scheie genetic compound (mucopolysaccharidosis IH/IS) in Japanese brothers. Clin Genet 1974; 6:394-400.
125. Kameen A, Jr, Maumenee IH, Green WR. Light and electron microscopic studies of the cornea in systemic mucopolysaccharidosis, type I-HS. Cornea 1986; 5:107-114.
126. Kangas TA, Edelhauser HF, Twining SS, O’Brien WJ. Loss of stromal glycosaminoglycans during corneal edema. Invest Ophthalmol Vis Sci 1990; 31:1994-2002.
127. Karumanchi SA, Jha V, Ramchandran R, et al. Cell surface glypicans are low-affinity endostatin receptors. Molec Cell 2001; 7:811-22.
128. Kenyon KR. Ocular manifestations and pathology of systemic mucopolysaccharidoses. Birth Defects 1976; 12:133-53.
129. Kenyon KR, Quigley HA, Hussels IE, Wyllie RG. The systemic mucopolysaccharidoses: ultrastructural and histochemical studies of conjunctiva and skin. Am J Ophthalmol 1972; 73:811-33.
130. Kenyon KR, Topping TM, Green WR, Maumenee AE. Ocular pathology of the Maroteaux-Lamy syndrome (systemic mucopolysaccharidosis type VI): histologic and ultrastructural report of two cases. Am J Ophthalmol 1972; 73:718-41.
131. Kiefer MC, Ishihara M, Swiedler SJ, et al. The molecular biology of heparan sulfate fibroblast growth factor receptors. Ann NY Acad Sci 1991; 638:167-76.
132. Klika E, Kloucek F. L’histochimie et l’ultrastructure de la cornée dans un cas de gargoylisme. Ophthalmologica 1966; 151:568-79.
133. Klintworth GK. The cornea-structure and macromolecules in health and disease: a review. Am J Pathol 1977; 89:719-808.
134. Klintworth GK, Smith CF. Difference between glycosaminoglycans synthesized by corneal and cutaneous fibroblasts in culture. Lab Invest 1981; 44:553-9.
135. Klintworth GK, Smith CF, Bowling BL: CHST6 mutations in North American subjects with macular corneal dystrophy: a comprehensive molecular genetic review. Molec Vis 2006; 12:159-76.
136. Klintworth GK, Vogel FS. Macular corneal dystrophy: an inherited acid mucopolysaccharide storage disease of the corneal fibroblast. Am J Pathol 1964; 45:565-86.
137. Knecht J, Cifonelli JA, Dorfman A. Structural studies on heparitin sulfate of normal and Hurler tissues. J Biol Chem 1967; 242:4652-61.
138. Kojima T, Shworak NW, Rosenberg RD. Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line. J Biol Chem 1992; 267:4870-7.
139. Kornblihtt AR, Gutman A. Molecular biology of the extracellular matrix proteins. Biol Reviews Cambridge Phil Soc 1988; 63:465-507.
140. Kresse H, Neufeld EF. The Sanfilippo A corrective factor:purification and mode of action. J Biol Chem 1972; 247:2164-70.
141. Kressler RJ, Aegerter EE. Hurler’s syndrome (gargoylism):a summary of literature and report of case with autopsy findings. J Pediatr 1938; 12:579-91.
142. Krivit W, Pierpoint ME, Ayaz K, et al. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). N Eng J Med 1984; 311:1606-11.
143. Landers RA, Tawara A., Varner HH, Hollyfield JG. Proteoglycans in the mouse interphotoreceptor matrix. IV Retinal synthesis of chondroitin sulfate proteoglycan. Exp Eye Res 1991; 52:65-74.
144. Lavery MA, Green WR, Jabs EW, et al. Ocular histopathology and ultrastructure of Sanfilippo’s syndrome, type III B. Arch Ophthalmol 1983; 101:1263-74.
145. Leisti J, Rimoin DL, Kaback MM, et al. Phenotypic variation in alpha-L-iduronidase deficiency, letter to the editor. Lancet 1975; 1:1344.
146. Li W, Vergnes JP, Cornuet PK, Hassell JR. cDNA clone to chick corneal chondroitin/dermatan sulfate proteoglycan reveals identity to decorin. Arch. Biochem. Biophys. 1992; 296:190-7.
147. Lie SO, Schofield BH, Taylor HA Jr, Doty SB. Structure and function of the lysosomes of human fibroblasts in culture: dependence on medium pH. Pediatr Res 1973; 7:13-9.
148. Lopez-Casillas F, Cheifetz S, Doody J, et al. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 1991; 67:785-95.
149. Lorenzo P, Aspberg A, Onnerfjord P, et al. Identification and characterization of asporin: a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J Biol Chem 2001; 276:12201-11.
150. McDonnell JM, Green WR, Maumenee IH. Ocular histopathology of systemic mucopolysaccharidosis, type II-A (Hunter syndrome, severe). Ophthalmology 1985; 92:1772-9.
151. McKusick VA. Mendelian Inheritance in Man. Catalogs of Autosomal Dominant, Autosomal Recessive and X-linked Phenotypes, 10th ed. Baltimore, MD: Johns Hopkins University Press, 1992.
152. McKusick VA, Howell RR, Hussels IE, et al. Allelism, non-allelism, and genetic compounds among the mucopolysaccharidoses. Lancet 1972; 1:993-6.
153. Mailer C. Gargoylism associated with optic atrophy. Can J Ophthalmol 1969; 4:266-71.
154. Mali M, Jaakkola P, Arvilommi AM, Jalkanen M. Sequence of human syndecan indicates a novel gene family of integral. J Biol Chem 1990; 265:6884-9.
155. Malley DS, Steinert RF, Puliafito CA, Dobi ET. Immunofluorescence study of corneal wound healing after excimer laser anterior keratectomy in the monkey eye. Arch Ophthalmol 1990; 108:1316-22.
156. Maroteaux P. Un nouveau type de mucopolysaccharidose avec athétose et elimination urinaire de kératin-sulfate. Presse Med 1973; 81:975-9.
157. Maroteaux P, Lévêque B, Marie J, Lamy M. Une nouvelle dysotose avec élimination urinaire de chondroitinesulfate B. Presse Med 1963; 71:1849-52.
158. Martin GR, Timpl R. Laminin and other basement membrane components. Annul Rev Cell Bio 1987; 3:57-85.
159. Marynen P, Zhang J, Cassiman J, et al. Partial primary structure of the 48-and 90-kilodalton core proteins of the cell surface-associated heparan sulfate proteoglycans of lung fibroblasts: prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts. J Biol Chem 1989; 264:7017-24.
160. Matalon R, Arbogast B, Justice P, et al. Morquio’s syndrome: deficiency of a chondroitin sulfate N-acetylhexosamine sulfate sulfatase. Biochem Biophys Res Commun 1974; 61:709-15.
161. Matalon R, Dorfman A. Hurler’s syndrome: biosynthesis of acid mucopolysaccharides in tissue culture. Proc Natl Acad Sci USA 1966; 56:1310-6.
162. Matsuda H, Satake Y, Katsumata H. Ultrastructural observations of the cornea of Hurler’s syndrome. Acta Soc Ophthalmol Jap 1970; 74:47-56.
163. Meyer K. Biochemistry and biology of mucopolysaccharides. Am J Med 1969; 47:664-72.
164. Midura, RJ, Hascall, VC. Analysis of the proteoglycans synthesized by corneal explants from embryonic chicken. II. Structural characterization of the keratan sulfate and dermatan sulfate proteoglycans from corneal stroma. J Biol Chem 1989; 264:1423-30.
165. Miyamoto T, Inoue H, Sakamoto Y, et al. Identification of a novel spice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci 2005; 46:2726-35.
166. Murdoch AD, Dodge GR, Cohen I, et al. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem 1992; 267:8544-57.
167. Murillo-Lopez F, Politi L, Adler R, Hewitt AT. Proteoglycan synthesis in cultures of murine retinal neurons and photoreceptors. Cell Mol Neurobiol 1991; 11:579-91.
168. Naumann G. Clearing of cornea after perforating keratoplasty in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) (letter). N Engl J Med 1985; 312:995.
169. Neufeld EF. Replacement of genotype-specific proteins in mucopolysaccharidoses. In: Bergsma D, Desnick RJ, Berlohr RW, Krivit W, eds. Enzyme Therapy in Genetic Diseases. Baltimore, MD: Williams & Wilkins, 1973:27-30.
170. Neufeld EF, Cantz MJ. Corrective factors for inborn errors of mucopolysaccharide metabolism. Ann NY Acad Sci 1971; 179:580-7.
171. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In:Scriver CR, Beudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, vol. 2. New York, NY: McGraw-Hill, 1989:1565-87.
172. Neuhauser EBD, Griscom NT, Gilles FH, Crocker AC. Arachnoid cysts in the Hurler-Hunter syndrome. Ann Radiol 1968; 11:453-69.
173. Newell FW, Koistinen A. Lipochondrodystrophy (gargoylism):pathologic findings in five eyes of three patients. Arch Ophthalmol 1955; 53:45-62.
174. Nieduszynski IA., Huckerby TN, Dickenson JM, et al. Structural aspects of skeletal keratan sulphates. Biochem Soc Trans 1990; 18:792-3.
175. Nieduszynski IA, Huckerby TN, Dickenson JM, et al. There are two major types of skeletal keratan sulphates. Biochem J 1990; 271:243-5.
176. Nishiu J, Tanaka T, Nakamura Y. Identification of a novel gene (ECM2) encoding a putative extracellular matrix protein expressed predominantly in adipose and femalespecific tissues and its chromosomal localization to 9q22.3. Genomics 1998; 52:378-81.
177. Njå A. A sex-linked type of gargoylism. Acta Pediatr. 1946; 33:267-86.
178. Noonan DM, Fulle A, Valente P, et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991; 266:22939-47.
179. O’Brien JF, Cantz M, Spranger J. Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetyl-galactosamine-4-sulfatase. Biochem Biophys Res Commun 1974; 60:1170-7.
180. Oettinger HF, Streeter H, Lose E, et al. Chromosome mapping of the murine syndecan gene. Genomics 1991; 11:334-8.
181. Oliveira AM, Perez AR, Cin PD, et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 2005; 24:3419-26.
182. Opitz JM. The Golabi-Rosen syndrome: report of a second family. Am J Med Genet 1984; 17:359-66.
183. Paigen K, Noell WK. Two linked genes showing a similar timing of expression in mice. Nature 1961; 190:148-50.
184. Paine-Saunders S, Viviano BL, Sauders S. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13. Genomics 1999; 57:455-8.
185. Pellegata NS, Dieguez-Lucena JL, Joensuu T, et al. Mutations in KERA, encoding keratacan, cause cornea plana. Nature Genet 2000; 25:91-5.
186. Philippart M, Sugarman GI. Chondroitin-4-sulfate mucopolysaccharidosis:a new variant of Hunter’s syndrome. Lancet 1969; 2:854.
187. Pierce A, Lyon M, Hampson IN, et al. Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver. J Biol Chem 1992; 267:3894-900.
188. Pilia G, Hughes-Benzie RM, MacKenzie A, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet 1996; 12:241-7.
189. Pouliquen Y, Faure JP, Bisson J, Desvignes P. Ultrastructure de la cornée dans un cas de polydystrophie de Hurler. Arch Ophtalmol (Paris) 1967; 27:495-512.
190. Prange CK, Pennacchio LA, Lieuallen K, et al. Characterization of the human neurocan gene, CSPG3. Gene 1998; 221:199-205.
191. Praus R, Goldman JN. Glucosaminoglycans in human corneal buttons removed at keratoplasty. Ophthalmic Res 1971; 2:223-30.
192. Pulkkinen L, Alitalo T, Krusius T, Peltonen L. Expression of decorin in human tissues and cell lines and defined chromosomal assignment of the gene locus (DCN). Cytogenet. Cell Genet. 1992; 60:107-11.
193. Pusch CM, Zeitz C, Brandau O, et al. The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich protein. Nature Gene 2000; 26:324-7.
194. Quantock AJ, Meek KM, Brittain P, et al. Alteration of the stromal architecture and depletion of keratan sulphate proteoglycans in oedematous human corneas: histological, immunochemical and X-ray diffraction evidence. Tissue Cell 1991; 23:593-606.
195. Quigley HA, Goldberg MF. Scheie syndrome and macular corneal dystrophy: an ultrastructural comparison of conjunctiva and skin. Arch Ophthalmol 1971; 85:553-64.
196. Quigley HA, Kenyon KR. Ultrastructural and histochemical studies of a newly recognized form of systemic mucopolysaccharidosis (Maroteaux-Lamy syndrome, mild phenotype). Am J Ophthalmol 1974; 77:809-18.
197. Quigley AH, Maumenee AE, Stark WJ. Acute glaucoma in systemic mucopolysaccharidosis I-S. Am J Ophthalmol 1975; 80:70-2.
198. Rasteiro A. Nota anatomica-clinica: sindroma de Scheie. Exp Ophthalmol 1977; 3:62-4.
199. Reardon A, Heinegard D, McLeod D. The large chondroitin sulphate proteoglycan versican in mammalian vitreous. Matrix Biol 1998; 17:325-33.
200. Robbins RA, Wagner WD, Register TC, Caterson B. Demonstration of a keratan sulfate-containing proteoglycan in atherosclerotic aorta. Arterioscler Thromb 1992; 12:83-91.
201. Rodriquez-Criado G, Mangano L, Segovia M, et al. Clinical and molecular studies on two further families with Simpson-Golabi-Behmel syndrome. Am J Med Genet 2005; 138A:272-7.
202. Rosen DA, Edmison DR, Robertson DM. Five year maintenance of corneal graft normality in systemic mucopolysaccharidosis. Can J Ophthalmol 1972; 7:445-53.
203. Rosen DA, Haust MD, Yamashita T, Bryans AM. Keratoplasty and electron microscopy of the cornea in systemic mucopolysaccharidosis (Hurler’s disease). Can J Ophthalmol 1968; 3:218-30.
204. Rouzier C, Vanatka R, Bannwarth S, et al. A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet 2006; 69:271-6.
205. Rummelt V, Meyer HJ, Naumann GOH. Light and electron microscopy of the cornea in systemic mucopolysaccharidosis type I-S (Scheie’s syndrome). Cornea 1992; 11:86-92.
206. Ruoslahti E. Structure and biology of proteoglycans. Ann Rev Cell Biol 1988; 4:229-55.
207. Saghatelyan A, de Chevigny A, Schachner M, Lledo P-M. Tenascin-R mediates activity-dependent recruitment of neuroblasts in the adult mouse forebrain. Nature Neurosci 2004; 7:37-356.
208. Sanfilippo SJ, Podosin R, Langer LO, Good RA. Mental retardation associated with acid mucopolysacchariduria (heparitin sulfate type). Pediatr 1963; 63:837-8.
209. Saunders S, Jalkanen M, O’Farrell S, Bernfield M. Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 1989; 108:1547-56.
210. Sawaguchi S, Yue BYJT, Chang I, et al. Proteoglycan molecules in keratoconus corneas. Invest Ophthalmol Vis Sci 1991; 32:1846-53.
211. Schaefer L, Babelova A, Kiss E, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005; 115:2223-33.
212. Scheie HG, Hambrick GW Jr, Barness LA. A newly recognized forme fruste of Hurler’s disease (gargoylism). Am J Ophthalmol 1962; 53:753-69.
213. Schrecengost PK, Blochberger TC, Hassell JR. Identification of chick corneal keratan sulfate proteoglycan precursor protein inwhole corneas and in cultured corneal fibroblasts. Arch Biochem Biophys 1992; 292:54-61.
214. Scott, JE, Bosworth, TR. The comparative chemical morphology of the mammalian cornea. Basic Appl Histochem 1990; 34:35-42.
215. Scott, JE, Haigh, M. Keratan sulphate and the ultrastructure of cornea and cartilage: a ‘stand-in’ for chondroitin in conditions of oxygen lack? J Anat 1988; 158:95-108.
216. Shows TB, Scrafford-Wolf LR, Brown JA, Meisler M. Assignment of b galactosidase gene (b-Gala) to chromosome 3 in man. Cytogenet Cell Genet 1978; 22:219-222.
217. Shull RM, Hastings NE, Selcer RR, et al. Bone marrow transplantation in canine mucopolysaccharidosis I:Effects within the central nervous system. J Clin Invest 1987; 79:435-43.
218. Shull R, Helman R, Spellacy E, Constantopoulos G. Morphologic and biochemical studies of canine mucopolysaccharidosis I Am J Pathol 1984; 114:487-95.
219. Shull RM, Munger RJ, Spellacy E, et al. Canine a-Liduronidase deficiency. Am J Pathol 1982; 109:244-8.
220. Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic and biochemical features of a new mucopolysaccharidosis. 1973; J Pediatr. 82:249-57.
221. Speizale P, Bardoni A, Balduini C. Interactions between bovine cornea proteoglycans and collagen. Biochem J 1980; 187:655-9.
222. Spranger J. The systemic mucopolysaccharidoses. Ergeb Inn Med Kinderheilkd 1972; 32:165-265.
223. Spranger J. Morphological aspects of the mucopolysaccharidoses. In: Holton JB, Ireland JT, eds. Inborn Errors of Skin, Hair and Connective Tissues. Baltimore, MD:University Park Press, 1975:39-65.
224. Spranger J, Schuster W. Chondroitin-4-sulphate mucopolysaccharidosis. Helv Pediatr Acta 1971; 26:387-96.
225. Staub E, Hinzmann B, Rosenthal A. A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defies a new protein family. FEBS Lett. 2002; 527:114--118, 2002.
226. Stevenson RE, Howell RR, McKusick VA, et al. The iduronidase deficient mucopolysaccharidoses: clinical and roentgenographic features. Pediatrics 1976; 57:111-22.
227. Stramm LE, Haskins ME, Aguirre G. Retinal pigment epithelial glycosaminoglycan metabolism: intracellular vs extracellular pathways. Invest Ophthalmol Vis Sci 1989; 30:2118-31.
228. Stramm L, Li W, Haskins M, Aguirre G. Glycosaminoglycan and collagen metabolism in arylsulfatase B-deficient retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci 1991; 32:2035-41.
229. Stramm L, Wolfe J, Schuchman E, et al. b-Glucuronidase mediated pathway essential for retinal pigment epithelial degradation of glycosaminoglycans. Disease expression and in vitro disease correction using retroviral mediated cDNA transfer. Exp Eye Res 1990; 50:521-32.
230. Stum M, Davoine C-S, Vicart S, et al. Spectrum of HSPG2 (perlecan) mutations in patents with Schwartz-Jampel syndrome. Hum Mutat 2006; 27:1082-91.
231. Summers CG, Purple RL, Krivit W, et al. Ocular changes in the mucopolysaccharidoses after bone marrow transplantation:a preliminary report. Ophthalmology 1989; 96:977-85.
232. Sutherland AE, Sanderson RD, Mayes M, et al. Expression of syndecan, a putative low affinity fibroblast growth factor receptor, in the early mouse embryo. Development 1991; 113:339-51.
233. Sztrovics R, Chen X-N, Grover J, et al. Localization of the human fibromodulin gene (FMOD) to chromosome 1q32 and completion of the cDNA sequence. Genomics 1994; 23:715-7.
234. Tabone E, Grimaud J-A, Peyrol S, et al. Ultrastructural aspects of corneal fibrous tissue in the Scheie syndrome. Virchows Arch [B] 1978; 27:63-7.
235. Taghavy A, Salsman K, Ledeen R. An abnormal ganglioside pattern from a gargoyle brain. Fed Proc 1964; 23:163.
236. Taketomi T, Yamakawa T. Glycolipids of the brain in gargoylism. Jap J Exp Med 1967; 37:11-21.
237. Tasheva ES, Pettanati M, von Kap-Her C, Conrad GW. Assignment of keratocan gene (KERA) to human chromosome band 12q22 by in situ hybridization. Cytogenet Cell Genet 2000; 88:244-5.
238. Tasheva ES, Pettenati M, von Kap-Her C, Conrad GW. Assignment of mimecan gene (OGN) to human chromosome band 9q22 by in situ hybridization. Cytogenet Cell Genet 2000; 88:326-7.
239. Tawara A, Hollyfield JG. Proteoglycans in the mouse interphotoreceptor matrix. III Changes during photoreceptor development and degeneration in the rds mutant. Exp Eye Res 1990; 51:301-15.
240. Thompson GR, Nelson NA, Castor CW, Grobelny SL. A mucopolysaccharidosis with increased urinary excretion of chondroitin-4-sulphate. Ann Intern Med 1971; 75:421-6.
241. Thonar EJ, Manicourt DM, Williams J, et al. Circulating keratan sulfate: marker of cartilage proteoglycan catabolism in osteoarthritis. J Rheumatol Suppl 1991; 27:24-6.
242. Threlked A, Adler R, Hewitt AT. Proteoglycan biosynthesis by chick embryo retina glial-like cells. Dev Biol 1989; 132:559-68.
243. Topping TM, Kenyon KR, Goldberg MF, Maumenee AE. Ultrastructural ocular pathology of Hunter’s syndrome, systemic mucopolysaccharidosis type II. Arch Ophthalmol 1971; 86:164-77.
244. Toselli C, Volpi U, Pirodda A. Contributo alla conoscenza della distrofia maculata del parenchima corneale (dystrophie mouchetée di François e Neetens). Ann Ottalmol 1966; 92:770-7.
245. Traupe H, van den Ouweland AM, van Oost BA, et al. Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. Genomics 1992; 13:481-3.
246. Tremblay M, Dubé I. Macular dystrophy of the cornea:ultrastructure of two cases. Can J Ophthalmol 1973; 8:47-53.
247. Tremblay M, Dube I, Gagne R. Altérations de la cornée dans the maladie de Scheie (mucopolysaccharidose type 1-S). Etude ultrastructurale. J Fr Ophthalmol 1979; 2:193-7.
248. Triggs-Raine B, Salo TJ, Zhang H, et al. Mutations in HYAL1, a member of a trandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lyosomal disorder, mucopolysaccharidosis IX. Proc Natl Acad Sci USA 1999; 96:6296-300.
249. Tripathi RC, Ashton N. Application of electron microscopy to the study of errors of metabolism. Birth Defects 1976; 12:69-104.
250. Tschumper RC, Johnson DH, Bradley JM, Acott TS. Glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Curr Eye Res 1990; 9:363-9.
251. Turnbull J, Powell A, Guimond S. Heparan sulfate:decoding a dynamic multifunctional cell regulator. Trends Cell Biol 2001; 11:75-82.
252. Uchimura Y, Toshima Y, Sekiya T. Zur elektonmikroskopischen Pathomorphologie der Hirnrinde bei Gargoylismus. Acta Neuropathol 1965; 4:476-90.
253. van Hoof F, Hers HG. The abnormalities of lysosomal enzymes in mucopolysaccharidoses. Eur J Biochem 1968; 7:34-44.
254. Vermeesch JR, Mertens G, David G, Marynen P. Assignment of the human glypican gene (GPC1) to 2q35-q37 by fluorescence in situ hybridization. Genomics 1995; 25:327-9.
255. Veugelers M, De Cat B, Ceulemans H, et al. Glypican-6, a new member of the glycipan family of cell surface heparan sulfate proteoglycans. J Biol Chem 1999; 274:26968-77
256. Veugelers M, De Cat B, Muyldermans SY, et al. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Molec Genet 2000; 9:1321-8.
257. Veugelers M, Vermeesch J, Reekmans G, et al. Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican family. Genomics 1997; 40:24-30.
258. Veugelers M, Vermeesch J, Watanabe K, et al. GPC4, the gene for human K-glypican, flanks GPC3 on Xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Genomics 1998; 53:1-11.
259. Vine D, McGovern M, Schuchman E, et al. Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association. J Clin Invest 1982; 69:294-302.
260. Vogler C, Birkenmeier EH, Sly WS, et al. A murine model of mucopolysaccharidosis VII: gross and microscopic findings in beta-glucuronidase-deficient mice. Am J Path 1990; 136:207-17.
261. Wallace BJ, Kaplan D, Adachi M, et al. Mucopolysaccharidosis type III: morphologic and biochemical studies of two siblings with Sanfilippo syndrome. Arch Pathol 1966; 82:462-73.
262. Wenger D, Gasper P, Thrall M, et al. Bone marrow transplantation in the feline model of arylsulfatase B deficiency. In: Krivit W, Paul N, eds. Bone Marrow Transplantation for Treatment of Lysosomal Storage Diseases. New York, NY: Alan R. Liss, 1986:177-86.
263. White DM, Mikol DD, Espinosa R, et al. Structure and chromosomal localization of the human gene for a brain form of prostaglandin D-2 synthase. J Biol Chem 1992; 267:23202-8.
264. Whitley C, Ramsey N, Kersey J, Krivit W. Bone Marrow Transplantation for Hurler Syndrome: Assessment of Metabolic Correction. In: Krivit W, Paul N, eds. Bone Marrow Transplantation for Treatment of Lysosomal Storage Diseases. New York, NY: Alan R. Liss, 1986:7-24.
265. Whiteley CB. The mucopolysaccharidoses. In: Beighton P, ed. McKusick’s Heritable Disorders of Connective Tissue. 5th ed. St. Louis, MO: CV Mosby, 1993:367-945.
266. Wiesmann U, Neufeld EF. Scheie and Hurler syndromes:apparent identity of the biochemical defect. Science 1970; 169:72-4.
267. Winchester P, Grossman H, Lim WN, Danes BS. A new mucopolysaccharidosis with skeletal deformities simulating rheumatoid arthritis. Am J Roentgenol 1969; 106:121-8.
268. Winterbotham CTC, Torczynski E, Horwitz AL, et al. Unusual mucopolysaccharide disorder with corneal and scleral involvement. Am J Ophthalmol 1990; 109:544-55.
269. Winters PR, Harrod MJ, Molenich-Heetred SA, et al. Alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Neurology 1976; 26:1003-7.
270. Wolfe J, Schuchman E, Stramm L, et al. Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by gene transfer. Proc Natl Acad Sci USA 1990; 87:2877-81.
271. Wollensak J, Buddecke E. Biochemical studies on human corneal proteoglycans: a comparison of normal and keratoconic eyes. Graefes Arch Clin Exp Ophthalmol 228:517-23.
272. Xiao X, Jia X, Guo X, et al. CSNB1 in Chinese families associated with novel mutations in NYX. J Hum Genet 2006; 51:634-40.
273. Yamada, H, Watanabe K, Shimonaka M, Tamaguchi, Y Molecular cloning of brevican, a novel brain proteoglycan of the aggregan/verican family. J. Biol. Chem. 1994; 269:10119-10126.
274. Yasuda Y, Tokita Y, Aono S, et al. Clong and chromosomal mapping of the human gene of neuroglycan C (NGC). A neural transmembrane chondrotin sulfate proteoglycan with an EGF module. Neurosci Res 1998; 32:313-22.
275. Yue BYJT, Baum JL, Silbert JE. The synthesis of glycosaminoglycans by cultures of corneal stromal cells from patients with keratoconus. J Clin Invest 1979; 63:545-51.
276. Zabel RW, MacDonald IM, Mintsioulis G, Addison DJ. Scheie’s syndrome: an ultrastructural analysis of the cornea. Ophthalmology 1989; 96:1631-8.
277. Zankl A, Bonafe L, Calcaterra V, et al. Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clin Genet 2005; 67:261-6.
278. Zimmerman DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan versican. EMBO J 1989; 8:2975-81.